Tag: QIAseq

Yushan Liu,1,2 Gezhi Zheng,1,3 Jing Li,1,3 Nan Yang,1– 4 Juan Li,1,2 Zhengwen Liu,1– 4 Qunying Han,1– 4 Yingren Zhao,1– 4 Fenjing Du,1,3 Yingli He,1,* Taotao Yan1,* 1Department of Infectious Diseases, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 2Institution of Hepatology, The First Affiliated…

Hi BioStar community, We have been routinely sequencing DNA samples using an Illumina MiSeq sequencer with CDI QIASeq Fx library kit. So far, we have not encountered any issues, as the MiSeq performed the demultiplexing process itself. However, in a recent run, the MiSeq failed to produce any fastq files…

Qiagen Co., Ltd.Qiagen Launches New Kit QIAseq Targeted cfDNA Ultra Panels in Japan Measure cancer recurrence and mutations from liquid biopsies. Highly accurate and easy to use, contributing to the spread of liquid biopsy research. Qiagen Co., Ltd. (Chuo-ku, Tokyo, President and CEO Shawn Sakashita, hereinafter QIAGEN) has released the…

Reports And Data The global rare biomarkers specimen collection stabilization market size is expected to reach USD 1983.36 Million in 2032, and register a revenue CAGR of 14%. NEW YORK, NEW YORK, UNITED STATES, April 23, 2023 /EINPresswire.com/ — The Global Rare Biomarkers Specimen Collection Stabilization Market is anticipated to…

Qiagen has announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer and other diseases to turn cell-free DNA (cfDNA) liquid-biopsy samples into libraries ready for next-generation sequencing (NGS) in less than eight hours. The new kit adds another innovation to the QIAseq Targeted DNA…

The QIAseq Targeted cfDNA Ultra Panels will help convert cfDNA liquid-biopsy samples into libraries ready for NGS. Credit: Miroslaw Miras from Pixabay. Netherlands-based Qiagen has introduced new QIAseq Targeted cell-free DNA (cfDNA) Ultra Panels to advance cancer research. Researchers studying cancer and other diseases can use the new panels to…

The global carrier screening market is expected to record a CAGR of 12.4% between 2023 and 2033, with a size estimated in 2023 at US$ 1,343.40 million. The market’s value is expected to rise to US$ 4,323.84 million by 2033. As a result of increased funding from the public and commercial sectors…

Venlo, the Netherlands, April 14, 2023 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer and other diseases to turn cell-free DNA (cfDNA) liquid-biopsy samples into libraries ready for next-generation sequencing (NGS) in…

Bioinformatics Market is Projected to Reach USD 29.32 Billion by 2030: Cognitive Market Research What is Bioinformatics? Bioinformatics is related to genetics and genomics, which involves the use of computer technology to store, collect, analyze, and disseminate biological information, and data, such as DNA and amino acid sequences or annotations…

Mutation Detection Kits in Genome Editing Market Mutation Detection Kits In Genome Editing Market: Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, TALENs/MegaTALs, ZFN, Mega nucleases), By End-use, and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America) Get a FREE Sample Copy of this Report…

PRESS RELEASE Published April 3, 2023 Gene Amplification Technologies Market crossed US$ 3.20 billion mark in 2022 and is expected to hit US$ 4.41 billion by 2030, recording a CAGR of 4.10% during the forecast period. The Gene Amplification Technologies Market research report by Business Market Insights includes Market segmentation and…

Global Remote Healthcare Remote Diagnostics Market size is expected to reach USD 4.1 billion at a CAGR of 13% over the forecast period 2023 to 2028. LAS VEGAS, NEVADA, UNITED STATES, March 11, 2023 /EINPresswire.com/ — Originally Posted : www.globalmarketstudies.com/ngs-sample-preparation-market-development-and-trends/ A recent report by the Global Market Studies has estimated…

This prospective observational study (NCT04803695) complied with the Declaration of Helsinki (current version, Fortaleza, Brazil, October 2013). Our institution’s Internal Review Board approved the study, and all patients gave their written informed consent (No. HCB/2018/0236, Hospital Clinic Barcelona). Sputum samples and DNA extraction Thirty-three sputum samples were collected from patients…

NEWARK, Del, March 08, 2023 (GLOBE NEWSWIRE) — The global carrier screening market is expected to record a CAGR of 12.4% between 2023 and 2033, with a size estimated in 2023 at US$ 1,343.40 million. The market’s value is expected to rise to US$ 4,323.84 million by 2033. As a…

Applications of SOPHiA DDM will support a wide range of applications using Qiagen Sophia Genetics, a Switzerland-based cloud-native software company in the healthcare space, has announced a new partnership with Qiagen that will pair QIAseq reagent technology with the SOPHiA DDM platform to enhance tumour analysis through next-generation sequencing (NGS). The partnership…

Sophia Genetics and Qiagen on Wednesday announced that they are collaborating to pair Qiagen’s QIAseq reagent technology with the Sophia DDM platform to use next-generation sequencing (NGS) to enhance tumor analysis. The Sophia DDM cloud-based platform uses machine learning to call, annotate, and pre-classify variants from raw NGS data. Under…

First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN’s QIAseq reagent technology with SOPHiA GENETICS DDM platform to expand compatibility with data-driven medicine Collaboration to initially support somatic variant detection using QIAseq panels for…

Credit: Nobi_Prizue/Getty Images QIAGEN announced today that it has entered a partnership with data-driven medicine software company SOPHiA GENETICS aimed at enhancing the compatibility of QIAseq kits for NGS secondary analysis and tertiary interpretation workflows via the SOPHiA DDM digital analytics platform. The partnership marks the launch of the QIAseq…

NEW YORK – Qiagen said Wednesday that it is collaborating with Sophia Genetics under a new partnership platform program for its QiaSeq next-generation sequencing reagent technology. With the new program, Hilden, Germany-based Qiagen seeks to integrate ordering of its QiaSeq kits and processing of test results with secondary analysis and…

QIAseq FX DNA Library Kit Protocol Procedure: 1. Acquire high quality gDNAsamples. 2. Set up a thermocycler to incubate for 30 minutes at 32℃, with the heated lid at 70℃. Run the program and pause until the block reaches 4℃. 3. In a tube on ice, prepare and mix the…

It’s exciting that advancements in high-throughput sequencing techniques and analysis enable us to generate whole genome (WGS) and whole exome (WES) data in bulk for many species, including humans. With new machines and chemistries, the cost of sequencing has decreased significantly. However, the total cost of ownership associated with bioinformatic…

The global carrier screening market is expected to record a CAGR of 12.4% between 2023 and 2033, with a size estimated in 2023 at US$ 1,343.40 million. The market’s value is expected to rise to US$ 4,323.84 million by 2033. As a result of increased funding from the public and…

Genetic Technologies on Wednesday announced it is forming a strategic alliance with Qiagen to establish and develop a Centre of Excellence in Australia that will initially serve Australian and New Zealand markets. Genetic Technologies said that the strategic alliance is expected to open commercial opportunities involving automation and increased capacity…

In allograft monitoring of solid organ transplant recipients, liquid biopsy has emerged as a novel approach using quantification of donor-derived cell-free DNA (dd-cfDNA) in plasma. Despite early clinical implementation and analytical validation of techniques, direct comparisons of dd-cfDNA quantification methods are lacking. Furthermore, data on dd-cfDNA in urine is scarce…

In allograft monitoring of solid organ transplant recipients, liquid biopsy has emerged as a novel approach using quantification of donor-derived cell-free DNA (dd-cfDNA) in plasma. Despite early clinical implementation and analytical validation of techniques, direct comparisons of dd-cfDNA quantification methods are lacking. Furthermore, data on dd-cfDNA in urine is scarce…

NEW YORK – Helix and Qiagen have formed an exclusive global partnership to develop and commercialize companion diagnostics for hereditary diseases, the firms announced on Thursday. Financial terms of the partnership were not disclosed. The collaboration will address the health burden of hereditary neurodegenerative, cardiovascular, autoimmune, and inflammatory diseases, the…

According to a new market research study of “Digital Genome Market to 2027 – Global Analysis and Forecast by Product, Application, and End User,” the global digital genome market is expected to reach US$ 20,812.81 million in 2027 from US$ 11,065.31 million in 2019. The market is estimated to grow…

Within analysis, low-coverage whole-genome sequencing out of cfDNA was held to examine blood plasma away from patients with spine metastasis An analysis pipe is made and you will verified to evaluate the brand new CNV condition within the cfDNA, in order to determine whether brand new CIN score, that has…

LA JOLLA, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Agilent Technologies (www.agilent.com) to validate its NGS Target Enrichment Products, highly sensitive target enrichment panels…

Trimmomatic – can`t find a path for to file 1 I simply need to run Trimmomatic, but he doesn`t see input files. May be you know how to deal with it? #creating variables INPUT_DIR=”path/folderinput” OUTPUT_DIR=”path/folderoutput” APPENDIX=”.fastq.gz” APPENDIX1=”_R1.fastq.gz” APPENDIX2=”_R2.fastq.gz” TRIMMOMATIC=”java -jar /home/path/trimmomatic-0.36.jar” #creating a loop for i in $INPUT_DIR/*$APPENDIX1 do FORWARD=$(basename…

miRDeep2: Mapped reference id is not an id of the genome file genome_nowhitespace.fa 1 Hi everyone, I’m trying to run nf-co.re/smrnaseq pipeline and I’m having a problem with mirdeep2. Command: nextflow run nf-core/smrnaseq -profile ijcluster –input /home/794_both.fastq.gz –outdir /home/results –genome GRCh38 –protocol qiaseq –mature mirbase.org/ftp/CURRENT/mature.fa.gz –hairpin mirbase.org/ftp/CURRENT/hairpin.fa.gz Error message: Command…

Study approval was provided by the Research Ethics Committee of the University of Perugia (report n.2018-21 of 11/12/2018) according to Italian Ministry of Health legislation18. All methods were carried out following relevant guidelines and regulations and the study was carried out in compliance with the ARRIVE guidelines. Informed consent is…

Analyzing and slicing FASTQ file entries using Python 1 I have the code pasted below for running on FASTQ file entries in order to compare specific parts and remove the redundancy of the same sequences (based on the miRNA + umi_seq combination). I save the entry IDs and then make…

QIAseq 16S/ITS Screening Panel Primers? 0 Hello! I’m trying to analyze some metagenomic samples that are a mixture of bacteria and fungi. I used the QIAseq 16S/ITS Screening Panel Kit for library prep, and now I’m looking for the sequence of the 16S and ITS primers from that kit and…

The Reference Data Manager The QIAGEN Sets Reference Data Library tab gives access to the reference data used with the CLC Haplotype Calling plugin ready-to-use workflow. From the wizard you can download and configure the reference data. For the full documentation relating to QIAGEN Sets, please see the QIAGEN Sets…

QIAseq cfDNA Library Kit, 96 reactions   For 96 reactions on Illumina® sequencers: enzymes and buffers for cfDNA library prep, Illumina Adapter Plate 96-plex, Illumina Library Amplification Primer and PCR Master Mix   Features • Optimal conversion of cfDNA at every step from plasma to NGS library through highly efficient…